5 most recent filings and news items mentioning APOG. Updated every 60 seconds.
M&AJul 1, 2026Positive
Apogee Enterprises announced the completion of its acquisition of Kalwall Companies from the Keller family for up to $115 million. This strategic transaction strengthens Apogee's market position by integrating differentiated daylighting capabilities and a strong architectural bra
View filing at SEC.gov →
Earnings|GuidanceJun 26, 2026Positive
Apogee Enterprises reported a significant increase in earnings and gross margin for its first fiscal quarter of 2027. Management reaffirmed fiscal 2027 guidance while maintaining a disciplined approach to capital allocation.
View filing at SEC.gov →
Trading IdeasJun 26, 2026Neutral
Nasdaq Falls For Fourth Day Amid Decline In Apple Shares: Investor Sentiment Declines, Greed Index Remains In ‘Fear’ Zone
View filing at SEC.gov →
M&AJun 22, 2026Positive
AbbVie Inc. has entered into a definitive merger agreement to acquire Apogee Therapeutics, Inc. through a subsidiary merger structure. The transaction expands AbbVie's therapeutic pipeline and represents a significant M&A activity in the pharmaceutical sector.
View filing at SEC.gov →
OtherJun 22, 2026Positive
Apogee Therapeutics signed an Antibody Discovery Agreement with Paragon Therapeutics effective June 17, 2026, for discovery and development of monospecific antibody candidates. The agreement includes a concurrent License Agreement enabling Apogee to further develop, manufacture a
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.